Recruiting studies: Antibody Mediated Rejection In Kidney Transplant

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Use of Extracorporeal Photopheresis in Kidney Transplantation: Effects on Antibody-Mediated Rejection
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire de Besancon · NCT07663669 TocIlizumab in Late/Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients
Phase 3 · 8 location(s) · Vastra Gotaland Region · NCT04561986 Treatment of Chronic Active Antibody Mediated Rejection With Tocilizumab
NA · 1 location(s) · Shahid Beheshti University of Medical Sciences · NCT07006532 Daratumumab for Late Antibody-Mediated Rejection
NA · 1 location(s) · University Hospital, Martin · NCT07081126 Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation
Phase 2 · 55 location(s) · Alexion Pharmaceuticals, Inc. · NCT06744647 Impact of ExtraCorporeal Phototherapy (ECP) on Auxiliary Follicular T-lymphocytes and Circulating B-lymphocytes During C
NA · 4 location(s) · University Hospital, Angers · NCT04870437 Peripheral and Intrarenal B Cell Study in Antibody Mediated Transplant Rejection : Phenotypic and Transcriptional Study,
Phase N/A · 2 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07134491

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.